News

20 Jul 2011
Cellectis bioresearch and Lonza achieve significant milestone on CHO-K1SV GS Knock-Out
Cellectis bioresearch successfully deactivated the cell-based glutamine synthetase (GS) activity in CHO-K1SV host cell line, allowing for accelerated clone selection and shortened...
05 Jul 2011
TALEN™ Access by Cellectis bioresearch receives Most Innovative New Service 2011 award at Life Science Awards
Cellectis bioresearch, a subsidiary of Cellectis (Alternext: ALCLS) and specialist in Genome customization, has received the "Most Innovative New Service 2011" award...
Copyright 2012 Cellectis
Design & Development by EtonDigital